
Vincerx Pharma (Nasdaq: VINC) terminates LOI with QumulusAI for potential merger, authorizes wind-down activities.
On April 8, 2025, Vincerx Pharma, Inc. (Nasdaq: VINC) from San Mateo, California, made an announcement that it has decided to end the non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., known as QumulusAI. This termination relates to a proposed merger between the two companies.

